Centene (CNC)
NYSEMarket Closed
Centene Corporation is a US managed care company built around government-sponsored health insurance programmes. Its core business is administering benefits for Medicaid members on behalf of states, while also serving people through Medicare products, Affordable Care Act marketplace plans, and Medicare Part D prescription drug coverage. This focus gives Centene a central role in healthcare access for lower-income families, people with complex health needs, seniors, and individuals buying subsidised coverage on the exchanges.
The company operates health plans across numerous US states and earns revenue primarily from premiums paid by government agencies and members. Medicaid remains its largest membership category, supported by long-term contracts with state governments that outsource care coordination and claims administration to private insurers. Centene also participates in the individual insurance exchanges, where it offers coverage to consumers who do not receive employer-sponsored insurance, and it maintains a smaller presence in Medicare, including drug plans.
Centene’s model depends on managing medical costs while meeting regulatory requirements and quality standards. It works with provider networks, pharmacies, and care management programmes to coordinate treatment, process claims, and support preventive care. Because its membership is heavily tied to public programmes, the company is sensitive to changes in state and federal healthcare policy, reimbursement rates, eligibility rules, and enrolment trends.
For investors, Centene is distinctive because it is one of the largest pure-play operators in government-backed managed care. Its scale, Medicaid expertise, and exchange footprint give it broad exposure to public healthcare spending, but also leave performance closely linked to regulation, contract renewals, and medical cost trends.
Last updated
- Market Cap
- $32,811,147,900
- P/E
- —
- P/FCF
- 3.67
- P/S
- 0.16
- Enterprise Value
- $24,765,147,900
- Sector
- Health Care
- Industry
- Managed Health Care
- Address
- 7700 FORSYTH BLVD., ST LOUIS, MO, 63105
Centene (CNC) Stock Fair Value Rises After Analysts Back Margin Recovery
Best Growth Stocks to Buy for August 25th
The Bull Case For Centene (CNC) Could Change Following CFO Transition To Chris Neczypor – Learn Why
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
1 Momentum Stock to Target This Week and 2 We Ignore
Mark Cuban says your 401(k) is ‘part of the cost of health care problem.’ Do you dump Big Insurance and own your values?
Oscar Health Flashes Buy Signal As Medicaid Weighs On Centene
S&P 500 Stock Centene Dives On Medicaid Outlook
The Real Risk Inside UnitedHealth Stock
UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost
Broader Market Settles Higher as Positive Inflation News Outweighs Chip Rout
Stocks Supported By Favorable Inflation News
Insurance stocks fall after Elevance Health results show margin pressure
Centene Corporation (CNC) Rallied Following the Robust Result
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down
Centene (CNC) Joins Growth Indexes On A Narrative That May Already Be Priced In
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports
RBC Initiates Centene (CNC) Coverage and Says the Worst of 2025 Is Firmly in the Rearview Mirror
Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $32,811,147,900
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $24,765,147,900
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.45
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.16
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 5.48
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.12
- EPS
- -10.32
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0.06%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 3.67
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 3.37
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- $8,951,000,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -22.6%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -6.14%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.71
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.34
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.34
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.29
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $4,123,845
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 66.42
Income Statement
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | 54.01B | 50.35B | 50.09B | 50.14B | 49.11B |
| Cost of revenue | 39.03B | 38.3B | 41.49B | 40.9B | 38.81B |
| Gross profit | 14.99B | 12.05B | 8.61B | 9.24B | 10.31B |
| Operating income | 1.64B | 2.26B | -1.38B | -6.5B | -87M |
| EBITDA | 1.93B | 2.57B | -534M | 556M | 283M |
| Net income | 1.09B | 1.54B | -1.1B | -6.63B | -253M |
| Income taxes | 399M | 560M | -443M | -42M | 2M |
| Interest expense | -153M | -164M | -168M | -170M | -170M |
| Other operating expenses | 10.24B | 6.39B | 6.61B | 12.6B | 7.36B |
| Total operating expenses | 52.38B | 48.09B | 51.47B | 56.64B | 49.2B |
| Basic EPS | 2.21 | 3.13 | -2.24 | -13.5 | -0.51 |
| Diluted EPS | 2.19 | 3.11 | -2.25 | -13.5 | -0.51 |
Balance Sheet
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total assets | 83.01B | 81.18B | 76.75B | 82.09B | 86.4B |
| Total liabilities | 60.36B | 59.65B | 56.69B | 61.03B | 58.89B |
| Total equity | 22.66B | 21.53B | 20.06B | 21.06B | 27.5B |
| Cash & equivalents | 24.15B | 21.26B | 17.89B | 17.06B | 14.51B |
| Current assets | 43.71B | 42.12B | 37.41B | 41.58B | 37.48B |
| Current liabilities | 18.67B | 17.79B | 14.53B | 17.53B | 13.52B |
| Accounts payable | 17.97B | 16.83B | 13.8B | 16.88B | 13.52B |
| Receivables | 18.08B | 19.43B | 18.11B | 23.11B | 21.55B |
| Goodwill | 10.84B | 10.84B | 10.84B | 10.84B | 17.56B |
| Long-term debt | 16.11B | 16.37B | 17.4B | 17.58B | 17.58B |
Cash Flow
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | 3.59B | 4.37B | 437M | 1.36B | 1.79B |
| Investing cash flow | -353M | 89M | 660M | 1.24B | -899M |
| Financing cash flow | -259M | -1.06B | -187M | -10M | -1.17B |
| Change in cash | 2.98B | 3.39B | 910M | 2.59B | -288M |
| Net income | 1.09B | 1.54B | -1.1B | -6.63B | -259M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 144 — CENTENE CORP | View Filing | |
| edgar index | 144 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 144 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 144 — CENTENE CORP | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — CENTENE CORP | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 3 | Form 3 — DIAZ PAUL J | View Filing | |
| form 4 | Form 4 — DIAZ PAUL J | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Tyler Lauren M | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — COUGHLIN CHRISTOPHER J | View Filing | |
| form 4 | Form 4 — COUGHLIN CHRISTOPHER J | View Filing | |
| form 4 | Form 4 — EPPINGER FREDERICK H | View Filing | |
| form 4 | Form 4 — Samuels Theodore R. II | View Filing | |
| form 4 | Form 4 — Samuels Theodore R. II | View Filing | |
| form 4 | Form 4 — TANJI KENNETH | View Filing | |
| form 4 | Form 4 — Tyler Lauren M | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 3 | Form 3 — Tyler Lauren M | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — SMITH SUSAN RAYE | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 144 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Burdick Kenneth A | View Filing | |
| form 4 | Form 4 — Burdick Kenneth A | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| form 3 | Form 3 — Carson Michael A | View Filing | |
| form 3 | Form 3 — Carson Michael A | View Filing | |
| form 3 | Form 3 — Carson Michael A | View Filing | |
| form 3 | Form 3 — Finke Daniel P | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — BLUME JESSICA L. | View Filing | |
| form 4 | Form 4 — BLUME JESSICA L. | View Filing | |
| form 4 | Form 4 — Burdick Kenneth A | View Filing | |
| form 4 | Form 4 — Burdick Kenneth A | View Filing | |
| form 4 | Form 4 — COUGHLIN CHRISTOPHER J | View Filing | |
| form 4 | Form 4 — COUGHLIN CHRISTOPHER J | View Filing |